114 related articles for article (PubMed ID: 30227249)
1. Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor.
Rong R; Hu G; Wang W; Muroya Y; Miura T; Ogawa Y; Kohzuki M; Ito O
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():80-86. PubMed ID: 30227249
[TBL] [Abstract][Full Text] [Related]
2. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
Inscho EW; Imig JD; Deichmann PC; Cook AK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
[TBL] [Abstract][Full Text] [Related]
3. 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.
Savas Ü; Wei S; Hsu MH; Falck JR; Guengerich FP; Capdevila JH; Johnson EF
J Biol Chem; 2016 Aug; 291(32):16904-19. PubMed ID: 27298316
[TBL] [Abstract][Full Text] [Related]
4. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat.
Schwartzman ML; da Silva JL; Lin F; Nishimura M; Abraham NG
Nephron; 1996; 73(4):652-63. PubMed ID: 8856265
[TBL] [Abstract][Full Text] [Related]
6. Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
Ito O; Omata K; Ito S; Hoagland KM; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R822-30. PubMed ID: 11171663
[TBL] [Abstract][Full Text] [Related]
7. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney.
Kroetz DL; Huse LM; Thuresson A; Grillo MP
Mol Pharmacol; 1997 Sep; 52(3):362-72. PubMed ID: 9281597
[TBL] [Abstract][Full Text] [Related]
8. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
Cervenka L; Navar LG
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclooxygenase- and cytochrome p450-derived eicosanoids by heme oxygenase in the rat kidney.
Botros FT; Laniado-Schwartzman M; Abraham NG
Hypertension; 2002 Feb; 39(2 Pt 2):639-44. PubMed ID: 11882623
[TBL] [Abstract][Full Text] [Related]
10. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
[TBL] [Abstract][Full Text] [Related]
11. Glucagon increase after chronic AT
Mildner M; Müller-Fielitz H; Stölting I; Jöhren O; Steckelings M; Raasch W
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):505-518. PubMed ID: 28144709
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
Brewer J; Liu R; Lu Y; Scott J; Wallace K; Wallukat G; Moseley J; Herse F; Dechend R; Martin JN; Lamarca B
Hypertension; 2013 Nov; 62(5):886-92. PubMed ID: 24041954
[TBL] [Abstract][Full Text] [Related]
13. The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney.
Poloyac SM; Tortorici MA; Przychodzin DI; Reynolds RB; Xie W; Frye RF; Zemaitis MA
Drug Metab Dispos; 2004 Jul; 32(7):727-33. PubMed ID: 15205388
[TBL] [Abstract][Full Text] [Related]
14. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries.
Thorup C; Kornfeld M; Goligorsky MS; Moore LC
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S220-4. PubMed ID: 9892167
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.
Su P; Kaushal KM; Kroetz DL
Am J Physiol; 1998 Aug; 275(2):R426-38. PubMed ID: 9688677
[TBL] [Abstract][Full Text] [Related]
18. Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.
Oestreicher EM; Guo C; Seely EW; Kikuchi T; Martinez-Vasquez D; Jonasson L; Yao T; Burr D; Mayoral S; Roubsanthisuk W; Ricchiuti V; Adler GK
Kidney Int; 2006 Nov; 70(10):1759-68. PubMed ID: 17021606
[TBL] [Abstract][Full Text] [Related]
19. Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.
Lukaszewicz KM; Lombard JH
Clin Sci (Lond); 2013 Jun; 124(12):695-700. PubMed ID: 23438293
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
Demeilliers B; Mimran A; Jover B
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
